- Poster presentation
- Open Access
Surgical site infections rates among patients with craniotomy. Results of a prospective surveillance program in a university teaching hospital
© Ciercoles et al; licensee BioMed Central Ltd. 2015
- Published: 16 June 2015
- Staphylococcus Aureus
- Surveillance Program
- Bone Flap
- Antimicrobial Prophylaxis
- Elective Procedure
Surgical site infections (SSI) after neurosurgery have serious clinical consequences and increase costs. Surveillance of SSI after craniotomy is not carried out enough.
To describe the results of a SSI surveillance program among patients after craniotomy.
Prospective surveillance in a 700-bed university hospital in Barcelona, Spain. The study included all patients admitted for elective or urgent craniotomy from October 2012 to December 2014. All craniotomies followed up within 30 days of surgery or after 1 year if implant inserted.
CDC definitions for SSI were used. Prosthetic implants included plates and screws for cranial osteosynthesis.
Overall, 469 patients were followed; 54% women, median age of 52 years (range: 18-84). Among them, 70% were elective procedures and 30% urgent or delayed. An implant to secure the bone flap to the skull was used in 426 (91%) patients. SSI developed in 61 patients (13%), organ/space 9%, deep incisional 3.5% and superficial 0.5%. Thirty-three patients (54%) required readmission. Mean days from surgery to infection were 40d. Comparison between patients with and without SSI did not show differences in age, sex, type of surgery (elective or urgent), implant insertion, operation duration, and adequacy of antimicrobial prophylaxis. SSI rates vary depending on ASA score and reason for neurosurgery. Common causative bacteria was Coagulase-negative staphylococci (33%) followed by Propionibacterium spp (26%) Staphylococcus aureus (21%) and gram negative bacilli (33%). Thirteen out of 61 episodes were polymicrobial.
Surveillance of craniotomy has allowed us to determine SSI rates and risk factors for SSI. Our results require the implementation of preventive measures.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.